Lv51
1370 积分 2021-07-20 加入
Applications of Contemporary Tools to Measure Plasma Protein Binding of Targeted Protein Degraders
2小时前
求助中
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine Metabolism
3小时前
已完结
In vitro-in vivo scaling of CYP-mediated metabolic clearance using a relative activity factor (RAF) approach
3小时前
求助中
Stereoselective pharmacokinetics of indobufen from tablets and intramuscular injections in man
18天前
已完结
Review of Dose Justifications for Antibody-Drug Conjugate Approvals from Clinical Pharmacology Perspective: a Focus on Exposure-Response Analyses
19天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
19天前
已完结
The landscape of small-molecule prodrugs
1个月前
已完结
Considerations in the Immunogenicity Assessment Strategy for Oligonucleotide Therapeutics (ONTs)
2个月前
已完结
Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability
2个月前
已完结
Importance of ADME for Anticancer Prodrugs
3个月前
已完结
皖公网安备34019202002308
